SHOP CANNABIS

Highs: Great CBD content for category. Reduced THC content for category. Includes CBG^✦. Great aid /w Pain**. HOT bargain pricing. Strong brand rating.

Lows: No product specific written reviews available.

About Sour Watermelon CBG:CBD Soft Chews

A bargain priced sativa dominant gummy at $0.26/g, produced in Ontario by Fireside using CO2 extraction in the Cannabis Edibles category with No THC potency and 4.7mg Moderate CBD content.

Using available terpene and strain data, we find Sour Watermelon CBG:CBD Soft Chews to have a 7/10 score for aid with pain** including help with anxiety and sleep, and overall product score (ePS) of 9/10 when compared to products in the same category, with a strong 4.5★ aggregate user rating across all Fireside branded products.

On-Label flavours:  watermelon,  sour.

Highs include: Great CBD content for category; Reduced THC content for category; Includes CBG; Great aid /w Pain**; HOT bargain pricing; Strong brand rating. Noted observations: No product specific written reviews available.

About Fireside

Fireside Cannabis isn’t just about quality; we’re also about connections. Connections to other people, to the nature surrounding us, and to new experiences. We’re 100% Canadian produced, and we’re damn proud of it!

Whether it’s backyard hangs, lakeside swims, or netflixing on the couch, our buds are for bonding. We’ve literally got something for everyone and every mood – Not to mention our cannabis looks great! (and they say you can’t judge a book by its cover).

Offered in dried flower, vapes, edibles and concentrates, we take pride in producing high-quality products that are just right for you and your crew.

About MediPharm Labs

A leader in cannabis extraction and purification, MediPharm Labs has invested in an expert team, state-of-the-art technology, advanced methodologies and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products.

Founded in 2015, MediPharm Labs Corp. is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation license. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification.